maintain

[키워드] 28-day mortality accompany acute lung injury adverse event airway All participant allergic anti-COVID19 IVIG Anti-viral Antibiotics assigned assisted ventilation autoimmune disorder blinded Blood oxygen saturation blood pressure C-IVIG Care Clinical efficacy Comparator group convalescent plasma COVID-19 COVID19 criteria Critically ill Critically ill patient CRP current disorder dosage Dyspnea excluded Follow-up four group group hemodynamic hemolytic anemia hospital hospital discharge Hospital stay hypersensitivity ICU IgA deficiency Ill immunization Immunoglobulin include infected individual Inflammation information inotropic agent Intervention intervention arm Isolation Karachi kidney Kidney failure lung infiltrate maintain Manifestations medication Meningitis MONITOR multiple organ dysfunction nasopharyngeal neutrophil lymphocyte ratio number objective observé oropharyngeal swabs outcome PaO parallel-group participant Passive passive immunization Patient patients positive SARS-CoV-2 PCR pregnant females Primary outcome protocol randomised randomised controlled randomised controlled trial randomization receive recruited Registered reported Respiratory failure respiratory rate Sample size sealed Septic shock shifting single dose standard care status Steroids Study protocol Support symptoms of COVID-19 therapy thromboembolic Total Treatment Trial university website were excluded with COVID-19
[DOI] 10.1186/s13063-020-04839-5 PMC 바로가기 [Article Type] Letter